美国FDA2005年药品安全警告[1]涉及药品14类约45种,比2004年药品安全警告[2]的10类约32种增加类别40%,品种41%。就神经精神药品而言,2004年警告中共17种,占总数的53%,其中抗抑郁症药和抗焦虑药10种,抗精神病药6种,抗多动症药1种;2005年警告中增至21种,占总数47%,其中抗抑郁症药 The U.S. Food and Drug Administration’s 2005 prevention and control of drug use cases covered about 45 drugs in 14 categories, an increase of 40% and 41% over the 32 categories in about 10 categories of drug safety warnings in 2004 [2]. As far as neuropsychiatric drugs are concerned, in 2004, 17 were warned of the CCP, accounting for 53% of the total, including 10 antidepressants and anti-anxiety drugs, 6 antipsychotics and 1 anti-hyperactivity drug; in 2005, the warning increased to 21 species, accounting for 47% of the total, including antidepressants